AAIPharma

AAIPharma, Inc. has appointed Ninad Deshpanday, Ph.D. to the newly created position of vice president of pharmaceutical business development. Dr. Deshpanday will be responsible for all North American business development activities in Pharmaceutical Development, including Analytical, Biotechnology, Formulations Development, GMP Manufacturing and Clinical Trial Materials for both Oral and Parenteral dosage forms.

Dr. Deshpanday has more than 15 years’ experience in pharmaceutical development. Prior to joining the company, he was vice president of drug product development for Synta Pharmaceuticals, with responsibilities for all CM&C activities. Prior to that, he served as technical business director for the pharmaceutics division of Cardinal Health. Previously, Dr. Deshpanday held leadership positions at AAIPharma, including senior manager of formulations development and global product director of pharmaceutics.

“Dr. Deshpanday possesses a unique combination of leadership skills and technical expertise in pharmaceutical development, and is a great addition to our business development team,” stated Pete Megronigle, senior vice president of North American business development. “This appointment represents AAIPharma’s continued focus on maximizing technical capabilities with regional effectiveness and broadening its position in the marketplace.”